Home
Editor's Corner
Welcome to the February 2021 edition of Vascular Disease Management. There are multiple articles of interest this month. I have chosen to comment on Dr. Osama Shoeib and colleagues’ article “Transradial Carotid Artery Stenting Complicated With Neck…
In this original research article, Bertolet et al take a look at how the VASCADE® Vascular Closure System (VCS) lowers rates of access site complications through a novel performance guarantee risk-sharing agreement between participating institutions and Cardiva Medical. With an estimated cost of $5,440 per bleeding complication, VASCADE® lowers vascular complications relative to national registries thereby reducing length of stay and complication costs, all while sharing financial risk.
Case Report
Carotid artery stenting (CAS)—when performed by an experienced operator using an embolic protection device—provides a good alternative for carotid…
Case Report
Superior vena cava syndrome (SVCS) represents a partial or total obstruction of the superior vena cava (SVC). The obstruction may be acute or chronic…
Case Report
Severe acute respiratory distress syndrome in association with coronavirus 2 (SARS-CoV-2) is a human coronavirus infection (COVID-19). At the time of…
Fellows’ Corner
Critical limb threatening ischemia (CLTI) is the manifestation of advanced lower extremity peripheral arterial disease (PAD), typically afflicting…
Meeting Spotlight
On-Demand Webcast
CME/CNE
On-Demand Webcast
CME/CNE
On-Demand Webcast
Radial Access: A Comprehensive Review of Clinical Applications and Techniques from the Radial Artery
CME/CNE
On-Demand Webcast
CME/CNE
Back to Top